Has Temilolu Aje, MD received payments from drug or device companies?

Yes. Drug and device makers reported $126 in general payments to Temilolu Aje, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Temilolu Aje, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Temilolu Aje, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Temilolu Aje, MD

Internal Medicine · Baltimore, MDNPI 1083816987

Payments from drug & device makers

$126in general payments, 2019–2025

Across 6 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Philips North America LLC$45
Lantheus Medical Imaging, Inc.$39
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$29
Amgen$13

What the payments were for

Food & beverage$126100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Philips North America LLC	2	$45
Lantheus Medical Imaging, Inc.	2	$39
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$29
Amgen	1	$13

How this compares

$126 in reported general payments places this provider in the 45th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$342,504

Medicare patients

2,525

Services billed

5,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	282	$377,879
XareltoRivaroxaban	73	$103,826
JardianceEmpagliflozin	36	$51,695
EntrestoSacubitril/Valsartan	24	$40,908
BrilintaTicagrelor	20	$20,957
Repatha SyringeEvolocumab	17	$17,718
Repatha SureclickEvolocumab	16	$14,912
Metoprolol Succinate	391	$5,923
Atorvastatin Calcium	337	$4,656
Losartan Potassium	153	$1,990
Rosuvastatin Calcium	89	$1,939
Digoxin	30	$1,678
Ezetimibe	51	$1,577
ClopidogrelClopidogrel Bisulfate	72	$1,312
Ranolazine ErRanolazine	18	$1,229

Paid to pharmacies, not to this prescriber.

Other internal medicine in Baltimore

Kristen MarroneBaltimore$5.6M
Peta-Gay Jackson BoothBaltimore$3.6M
Mark YarchoanBaltimore$2.4M
Gabrielle PrinceBaltimore$2.1M
Jessica TaoBaltimore$1.2M
Ana-Maria OrbaiBaltimore$1.1M
Julie PaikBaltimore$1M
Christopher MelaniBaltimore$997K
Ethel WeldBaltimore$792K
Christian GockeBaltimore$725K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →